Rocket Lab USA, Inc. (RKLB) Q1 2025 Earnings Call Transcript — Neutral

RKLB   Seeking Alpha — May 08, 2025

Rocket Lab USA, Inc. (NASDAQ:RKLB ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Murielle Baker - Senior Communications Manager Peter Beck - Founder and CEO Adam Spice - CFO Conference Call Participants Edison Yu - Deutsche Bank Gautam Khanna - TD Securities Ryan Koontz - Needham Andre Madrid - BTIG Matthew Akers - Wells Fargo Suji Desilva - ROTH Capital Jason Gursky - Citi Michael Leshock - KeyBanc Capital Markets Erik Rasmussen - Stifel Operator Thank you for standing by. My name is Jessica and I will be your conference operator today.

image for news Rocket Lab USA, Inc. (RKLB) Q1 2025 Earnings Call Transcript

AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript — Neutral

RCEL   Seeking Alpha — May 08, 2025

AVITA Medical, Inc. (NASDAQ:RCEL ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director, Investor Relations Jim Corbett - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Chris Kallos - MST Access Operator Good day, and thank you for standing by. Welcome to AVITA Medical First Quarter 2025 Earnings Conference Call.

image for news AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript

Eastman Kodak Company (KODK) Q1 2025 Earnings Call Transcript — Neutral

KODK   Seeking Alpha — May 08, 2025

Eastman Kodak Company (NYSE:KODK ) Q1 2025 Earnings Call May 8, 2025 5:00 PM ET Company Participants Anthony Redding - Chief Compliance Officer Jim Continenza - Executive Chairman and Chief Executive Officer David Bullwinkle - Chief Financial Officer and Senior Vice President Operator Good day and thank you for standing by. Welcome to the Eastman Kodak Quarter 1 Earnings Conference Call.

image for news Eastman Kodak Company (KODK) Q1 2025 Earnings Call Transcript

RingCentral, Inc. (RNG) Q1 2025 Earnings Call Transcript — Neutral

RNG   Seeking Alpha — May 08, 2025

RingCentral, Inc. (NYSE:RNG ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Vaibhav Agarwal - Deputy Chief Financial Officer Vlad Shmunis - Founder, Chairman and Chief Executive Officer Kira Makagon - President and Chief Operating Officer Abhey Lamba - Chief Financial Officer Conference Call Participants Meta Marshall - Morgan Stanley Kash Rangan - Goldman Sachs Billy Fitzsimmons - Jefferies Peter Levine - Evercore ISI Jessica Wang - Raymond James Catherine Trebnick - Rosenblatt Ronit Shah - Wells Fargo Operator Good day, and welcome to the RingCentral First Quarter 2025 Earnings Conference Call. All participants will …

image for news RingCentral, Inc. (RNG) Q1 2025 Earnings Call Transcript

Timothy Morse of Asymmetric Advisors discusses opportunities with Japan small-caps and says the ageing population is a 'tailwind' for the rapid consolidation of the domestic market.

image for news Analyst: Sees an 'appetite' for Japan domestic-related names, amidst rotation out of U.S. stocks

In its fiscal third quarter, Affirm's gross merchandise value jumped double digits, all but one spending category showed gains, underscoring the appeal of paying over time, and 1.8 million new consumers transacted within the platform's growing ecosystem.

image for news Affirm Card GMV Jumps 115%, Says It Can Weather ‘Recession Scenario'

Banco Santander Q1: Good, But Still Not Enough Again — Negative

SAN   Seeking Alpha — May 08, 2025

Santander Brasil's loan portfolio showed modest annual growth and a slight quarterly decline, reflecting a cautious, selective strategy amid high-interest rates. Non-Performing Loans increased slightly, with short-term NPLs rising 40 bps q/q and 30 bps y/y, particularly impacting individuals and SMEs. Net Interest Income grew by 0.3% q/q and 9.5% y/y to BRL 15.8 billion, driven by higher spreads and average volume.

image for news Banco Santander Q1: Good, But Still Not Enough Again

NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / PPTA NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Perpetua Resources Corp. Investors to Secure Counsel Before Important May 20 Deadline in Securities Class Action - PPTA WHY: New York, N.Y., May 8, 2025.

image for news PPTA NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Perpetua Resources Corp. Investors to Secure Counsel Before Important May 20 Deadline in Securities Class Action - PPTA

Trex Company, Inc. (TREX) Q1 2025 Earnings Call Transcript — Neutral

TREX   Seeking Alpha — May 08, 2025

Trex Company, Inc. (NYSE:TREX ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Casey Kotary - Head, IR Amy Fernandez - SVP, Chief Legal Officer & Secretary Bryan Fairbanks - President & CEO Brenda Lovcik - SVP & CFO Conference Call Participants Ryan Merkel - William Blair Rafe Jadrosich - Bank of America Tim Wjos - Baird Keith Hughes - Truist Susan Maklari - Goldman Sachs Collin Verron - Deutsche Bank Michael Rehaut - J.P. Morgan Ketan Mamtora - BMO Capital John Lovallo - UBS Phil Ng - Jefferies Trey Grooms - Stephens Matthew Bouley …

image for news Trex Company, Inc. (TREX) Q1 2025 Earnings Call Transcript

NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / WHY: New York, N.Y., May 8, 2025.

image for news TFII FINAL DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TFI International Inc. Investors to Secure Counsel Before Important May 13 Deadline in Securities Class Action - TFII

10x Genomics, Inc. (TXG) Q1 2025 Earnings Call Transcript — Neutral

TXG   Seeking Alpha — May 08, 2025

10x Genomics, Inc. (NASDAQ:TXG ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Cassie Corneau – Senior Director, Investor Relations Serge Saxonov – Chief Executive Officer and Co-Founder Adam Taich – Chief Financial Officer Conference Call Participants Patrick Donnelly – Citi Kyle Mikson – Canaccord Genuity Madeline Mollman – Wolfe Research Matt Sykes – Goldman Sachs Kyle Boucher – TD Cowen Operator Ladies and gentlemen, thank you so much for standing by and welcome to 10x Genomics First Quarter 2025 Earnings Conference Call. Please note that this call is being recorded.

image for news 10x Genomics, Inc. (TXG) Q1 2025 Earnings Call Transcript

Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive

NTRA   Zacks Investment Research — May 08, 2025

Although the revenue and EPS for Natera (NTRA) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

LPL Financial (LPLA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive

LPLA   Zacks Investment Research — May 08, 2025

Although the revenue and EPS for LPL Financial (LPLA) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news LPL Financial (LPLA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Here's What Key Metrics Tell Us About Ready Capital (RC) Q1 Earnings — Positive

RC   Zacks Investment Research — May 08, 2025

Although the revenue and EPS for Ready Capital (RC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Here's What Key Metrics Tell Us About Ready Capital (RC) Q1 Earnings

LPL Financial (LPLA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive

LPLA   Zacks Investment Research — May 08, 2025

Although the revenue and EPS for LPL Financial (LPLA) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news LPL Financial (LPLA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=147657&wire=1 or contact Joseph E. Levi, Esq.

image for news June 16, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ZBIO

NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your enCore Energy Corp. (NASDAQ:EU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/encore-energy-corp-lawsuit-submission-form?prid=147656&wire=1 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by May 13, 2025 Deadline to Join Class Action Against enCore Energy Corp.(EU)

NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sana-biotechnology-inc-lawsuit-submission-form?prid=147658&wire=1 or contact Joseph E. Levi, Esq.

image for news Shareholders that lost money on Sana Biotechnology, Inc.(SANA) should contact Levi & Korsinsky about pending Class Action - SANA

NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147655&wire=1 or contact Joseph E. Levi, Esq.

image for news Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - July 7, 2025 Deadline to Join - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations of federal securities laws. On May 1, 2025, Organon reported mixed Q1 FY25 results, missing expectations on revenue decline of 7% y/y to $1.51B.

image for news OGN STOCK ALERT: Levi & Korsinsky Notifies Organon & Co. Investors of an Ongoing Investigation